---
category: news
title: "Relay buys AI startup to aid unorthodox drug discovery quest"
excerpt: "The $85 million acquisition is an unusual and early step for a company like Relay, which went public last July and only just began clinical testing of its lead drugs last year."
publishedDateTime: 2021-04-16T16:29:00Z
originalUrl: "https://www.biopharmadive.com/news/relay-acquire-zebiai-ai-drug-discovery/598550/"
webUrl: "https://www.biopharmadive.com/news/relay-acquire-zebiai-ai-drug-discovery/598550/"
type: article
quality: 37
heat: 37
published: false

provider:
  name: BioPharma Dive
  domain: biopharmadive.com

topics:
  - AI

images:
  - url: "https://www.biopharmadive.com/user_media/cache/c5/72/c572d5a296c20a66f212559314e53244.jpg"
    width: 770
    height: 364
    isCached: true

secured: "RaUZvrxEfadwwKw/t24VE9sMPZP+T0SY5hbdXZxeXdxKZ9NPSAr4iSiubUpzct+mS8HxUJPscU644gOcuow306kn5E5oNsfbbZNhUWVxNJ91KUuGmRjv/tKunLCNU0LMYHPU8Z+LS/8KDceRSK+vKALj0ds3Bm9NO9+vRTuhySfMzPT4ba2ibGl/FCKs5CnUgLfJM1/v9H0zyY0r+3+2eZJ9U53KsbdYfZlwdAUxh8iiC/ZfuMMgf9n9QiKn4ZYfaL0ePiBGUjZVzcHV8qxjwI30dEMMh8Eca6kwKX7wEnaQbzJfuFjF0Vla8qQD8l+1cFFZ3zcAyrg/PJLPoSIJhH7ujC1Ri/TqNUSxYUkNCWg=;z97fSnqDwCNsi8pdfqILqg=="
---

